$7.4B Purdue Pharma Opioid Settlement, How Arkansas’s $44.5 Million Will Be Distributed

The Purdue Pharma Opioid Settlement is a $7.4 billion resolution with Purdue Pharma and the Sackler family, with Arkansas set to receive an estimated $44.5 million — distributed annually beginning next spring and continuing through 2040. The settlement became legally effective on May 1, 2026, capping nearly a decade of work by attorneys general across the country pursuing investigations and litigation over Purdue’s and the Sacklers’ role in fueling the opioid crisis. Funds are directed toward addiction treatment, prevention, and recovery — not individual claim forms.

Quick Facts: Purdue Pharma Opioid Settlement — Arkansas

Field	Detail
Total Settlement Amount	$7,400,000,000
Arkansas Share	$44,500,000 (estimated)
Claim Deadline	No individual claim form — funds distributed to state, counties, and municipalities
Who Benefits	Arkansas state government, counties, municipalities, and opioid victims who filed bankruptcy claims
Payout Per Person	TBD — individual victim payouts determined through bankruptcy proceedings
Settlement Status	Legally effective May 1, 2026
Administrator	Arkansas Attorney General’s Office (state share); local subdivisions for remainder
Official Source	arkansasag.gov
Last Updated	May 2, 2026

Current Status

• The $7.4 billion settlement went into legal effect on May 1, 2026, with the Sacklers paying more than $1.5 billion immediately, followed by approximately $500 million in May 2027, $500 million in May 2028, and $400 million in May 2029. Purdue is also paying approximately $900 million today.
• Arkansas’s $44.5 million will be dispensed annually beginning next spring and will continue through 2040, split into thirds among the state, municipalities, and counties.
• Purdue’s manufacturing operations have transferred to Knoa Pharma LLC effective May 1, 2026, overseen by a board of directors with no connection to Purdue.

What Is the Purdue Pharma Lawsuit About? In re Purdue Pharma L.P., No. 19-23649 (Bankr. S.D.N.Y.)

The settlement resolves litigation against Purdue and the Sacklers for producing and aggressively marketing opioids in the United States, fueling the largest drug crisis in the country’s history. Purdue made OxyContin — a powerful prescription painkiller — and prosecutors and attorneys general across the country alleged the company pushed it aggressively on doctors and patients while hiding or downplaying its addiction risk.

A coalition of attorneys general launched a multistate investigation of Purdue in 2016. After Purdue filed bankruptcy in September 2019 in light of massive litigation against it, the attorneys general took a lead role in the bankruptcy proceedings, including negotiating a new settlement that obtained more money from the Sacklers after the Supreme Court in June 2024 invalidated provisions in a prior settlement. That Supreme Court ruling was a turning point — it forced the Sacklers back to the table and produced a significantly larger payout for victims and states.

Fifty-five attorneys general, representing all eligible U.S. states and territories, signed onto the settlement in June 2025. Arkansas Attorney General Tim Griffin was among them, and his office pursued this case as part of a broader effort to hold opioid manufacturers accountable for the damage done to Arkansas communities. If you want to understand how states pursue these kinds of toxic exposure lawsuits, the opioid litigation is widely considered the largest coordinated state enforcement effort in U.S. history.

Who Benefits from the Purdue Pharma Settlement in Arkansas?

This settlement does not work like a traditional consumer class action — there is no online claim form and the money does not go into a fund that anyone can apply for. Here is how to know where Arkansas’s $44.5 million actually goes.

Arkansas’s portion will be split into thirds, with one third — about $14.8 million — being awarded to the state, managed by the Attorney General’s office; one third being awarded to Arkansas municipalities; and one third being awarded to Arkansas counties.

You may benefit from this settlement if:

• You are an Arkansas resident who has sought or currently needs opioid addiction treatment, recovery services, or prevention programs — these are the programs the state funds are earmarked to support
• Your city or county receives a direct disbursement and uses it for local treatment or recovery infrastructure
• You filed a personal injury or creditor claim in Purdue’s bankruptcy proceedings — a separate process for direct victims of OxyContin addiction

You are likely NOT a direct recipient if:

• You did not file a claim in the Purdue bankruptcy
• You are looking for a cash settlement payout from an online form — that process does not exist for this settlement

How Much Will Arkansas Receive and When?

Most settlement funds will be distributed in the first three years, with the Sacklers paying more than $1.5 billion immediately, approximately $500 million in May 2027, $500 million in May 2028, and $400 million in May 2029.

Arkansas will receive an estimated $44.5 million, dispensed annually beginning next spring and continuing through 2040. The three-way split means roughly $14.8 million goes to the state AG’s office, with the remaining two-thirds flowing to Arkansas’s counties and municipalities to fund local opioid response programs.

For direct opioid victims who filed personal injury claims in Purdue’s bankruptcy, individual payouts are determined separately through the bankruptcy court process. One recovery advocate estimated his personal direct payout would be roughly $3,500 — a figure that reflects how thin individual victim compensation becomes when spread across hundreds of thousands of claimants. The bulk of the funds are structured as community abatement money, not personal compensation.

What Should You Do If You Were Affected by Purdue Pharma’s Opioids?

Most Arkansans will not take any direct action here — the money flows through government channels automatically. But if you or someone you know has been personally harmed by OxyContin or another Purdue product, here are your practical options right now:

1. Contact the Arkansas Attorney General’s office at arkansasag.gov to ask how state opioid settlement funds are being allocated to treatment programs
2. Reach out to your county or city government to find out what local opioid recovery services your municipality’s share will fund
3. If you believe you have an individual personal injury claim that was not filed in the bankruptcy, speak with a toxic exposure attorney about whether any separate legal options remain — a free legal consultation can clarify your situation
4. Save any medical records, prescription records, or documentation connecting you or a family member to OxyContin or Purdue products, in case they are relevant to any future proceedings
5. Monitor arkansasag.gov for updates on how and when state-level funds will be distributed to treatment providers and communities

Purdue Pharma Settlement Timeline

Milestone	Date
Multistate Investigation Launched	2016
Purdue Pharma Bankruptcy Filed	September 2019
Arkansas Sued Purdue	2019
Prior Settlement Invalidated by Supreme Court	June 2024
New $7.4B Settlement Announced	January 2025
All 55 Attorneys General Sign On	June 2025
Arkansas AG Announces $44.5M Share	June 2025
Settlement Legally Effective	May 1, 2026
First Arkansas Payments Expected	Spring 2027
Final Payments to Arkansas	2040

Frequently Asked Questions

Is there a class action lawsuit against Purdue Pharma I can join right now? 

The litigation phase is over. The settlement became legally effective May 1, 2026, and all 55 U.S. attorneys general representing eligible states and territories signed on. The window to file new claims in Purdue’s bankruptcy proceedings has closed. If you have questions about individual options, consult a consumer rights lawyer.

Do I need to do anything right now to receive money from this settlement? 

For most Arkansans, no. The state, county, and municipal funds flow through government channels automatically. If you were a direct victim who filed a personal injury claim in Purdue’s bankruptcy, your payout is handled through those bankruptcy proceedings — not a new claim form.

When will Arkansas actually receive its $44.5 million? 

Funds will be dispensed annually beginning next spring and will continue through 2040. The first disbursements to states are expected to begin in 2027 based on the payment schedule currently in place.

Can I file my own lawsuit against Purdue Pharma or the Sacklers? 

The settlement permanently bars the Sacklers from selling opioids in the U.S. and resolves the multistate litigation. Filing new individual suits against Purdue is unlikely to be viable given the bankruptcy. A private attorney can advise you on whether any independent legal options remain for your specific situation.

How will I know what Arkansas does with the opioid settlement money? 

The Arkansas AG’s office manages the state’s one-third share and is expected to report on its allocation. Your county and city governments control their portions. Monitoring arkansasag.gov and your local government’s public announcements is the best way to track how funds reach treatment programs.

What happened to Purdue Pharma as a company? 

Purdue’s manufacturing operations transferred to Knoa Pharma LLC effective May 1, 2026, which is overseen by a board of directors who had no connection to Purdue. Knoa is prohibited from marketing opioids and operates under independent monitoring.

Will this settlement payment affect my taxes?

 If you receive a direct personal injury payment through the Purdue bankruptcy process, it may be taxable depending on what it compensates for. Speak with a tax professional about your specific payment type before filing.

Sources & References

• Arkansas Attorney General — Official $44.5M Settlement Announcement
• Michigan Attorney General — Settlement Goes Into Effect
• Pennsylvania Attorney General — Settlement Statement
• California Attorney General — Official Settlement Announcement

Prepared by the AllAboutLawyer.com Editorial Team and reviewed for factual accuracy against official state attorney general announcements and the Arkansas AG press release on May 2, 2026. Last Updated: May 2, 2026

Disclaimer: This article is for informational purposes only and does not constitute legal advice. Legal claims and outcomes depend on specific facts and applicable law. For advice regarding a particular situation, consult a qualified attorney.